Across TCGA patient cohorts, RPL26P9 RNA expression is significantly associated with the protein abundance of many other proteins, with 16,142 significant associations in total. LSCC shows the largest number of these associations.

The most reproducible RPL26P9-associated proteins across cancer lineages are DPYD, GBP2, and DOK2. Each is linked with RPL26P9 in more than 6 cancer types. Because this analysis shows association rather than direction, both RPL26P9-to-partner and partner-to-RPL26P9 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL26P9→partner) and Y-score (partner→RPL26P9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
GBM	DPYD →	+1.007	+1.023	<.001	<.001	3	7
UCEC	GBP2 →	+0.673	+1.132	<.001	<.001	3	7
GBM	DOK2 →	+0.547	+0.612	<.001	<.001	3	6
LSCC	DPYD_S905 →	+0.929	+0.768	<.001	<.001	3	6
UCEC	PPP1R18 →	+0.473	+0.859	<.001	<.001	3	6
GBM	CAPZA1 →	+0.349	+1.033	<.001	<.001	3	5

Each partner links to its Q-omics profile. Showing the 6 strongest of 16,142 associations by consensus.

Exploration

RPL26P9 survival (RNA) · tumor vs normal (RNA) · all RPL26P9 data types